Seiko Diane Yamada to Receptors, Vascular Endothelial Growth Factor
This is a "connection" page, showing publications Seiko Diane Yamada has written about Receptors, Vascular Endothelial Growth Factor.
Connection Strength
0.026
-
Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study. Lancet Oncol. 2012 Feb; 13(2):154-62.
Score: 0.026